Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
6.99
-0.13 (-1.83%)
At close: Aug 7, 2025, 4:00 PM
6.88
-0.11 (-1.57%)
Pre-market: Aug 8, 2025, 4:26 AM EDT
Endeavor Group Holdings Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $149.42 million as of August 8, 2025. Its market cap has decreased by -52.94% in one year.
Market Cap
149.42M
Enterprise Value
172.19M
1-Year Change
-52.94%
Ranking
Category
Stock Price
$6.99
Market Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has decreased from $289.30M to $149.42M, a decrease of -48.35%. That is a compound annual growth rate of -5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 149.40M | 22.56% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.30B |
| Johnson & Johnson | 412.60B |
| AbbVie | 345.36B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| Abbott Laboratories | 228.24B |
| UnitedHealth Group | 224.80B |
| Novo Nordisk | 210.71B |